However, the molecular mechanisms underlying the degeneration of dopaminergic (DA) neurons in LRRK2-G2019S PD patients remain unclear, and this lack of knowledge is a significant obstacle to understanding the disease’s etiology. The gene discussed is LRRK2; the disease is Parkinson disease.